Accueil/Actions/SXTP

SXTP

USD

60 Degrees Pharmaceuticals Inc. Common Stock

$1.230+0.000 (0.000%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$1.230

Haut

$1.269

Bas

$1.180

Volume

0.12M

Fondamentaux de l'Entreprise

Capitalisation Boursière

5.0M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.14M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.18Actuel $1.230Haut $12.45

Actualités Connexes

15 oct. 2025 · 11:14

GlobeNewswire

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

Breakthrough Therapy Designation request has been submitted to FDACompany to request a Type B meeting with FDA in early 2026 to discuss requirements for a supplementary New Drug Application (sNDA)Results obtained using

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

9 oct. 2025 · 11:04

GlobeNewswire

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study

Company engaged patients diagnosed with chronic babesiosis via social media in a nationwide naming competitionA $5K donation from the Company was split between ILADEF and GLA to recognize the winning nameB-FREE, a Phase